Your sitemaster has long argued that it is perfectly reasonable for many younger men diagnosed with low- and very low-risk forms of prostate cancer to be managed initially on active surveillance (despite reticence on the parts of many physicians and many patients). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, age, AS, Diagnosis, Management, surveillance | 2 Comments »
An interesting new article in The ASCO Post tells us almost as much about the physicians who treat prostate cancer as it does about the options that are available to patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, benefit, option, risk, surveillance | 11 Comments »
Many patients, prostate cancer advocates, and prostate cancer educators may be interested in a recent article exploring how physicians who manage prostate cancer regularly think about active surveillance (AS) and how to discuss this with their patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, clinician, concern, mindset, perspective, physician, surveillance | 1 Comment »
An interesting article published a couple of week’s ago in the Medical Journal of Australia reports on “real world issues” related to the implementation of active surveillance (AS) in Oz. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, AS, Australia, clinical, practice, protocol, standard, surveillance | 2 Comments »
We have previously reported data from the 2-year follow-up of the patients participating in the PCM301 trial of vascular targeted phototherapy (VTP) — a form of prostate hemiablation — compared to active surveillance in the treatment of low-risk, localized prostate cancer. New data at 4 years of follow-up have now been published in the Journal of Urology. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, outcome, photodynamic, surveillance, targeted, TOOKAD, vascular, VTP | 3 Comments »
At the annual meeting of the American Urological Association early this morning in San Francisco, we we given the initial report on the results of the Men’s Eating and Living (MEAL) trial. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: active, diet, MEAL, surveillance, trial, vegetable | 11 Comments »
So one of the more interesting things to be announced since your sitemaster arrived at the annual meeting of the American Urological Association (AUA) in San Francisco yesterday was this one: … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, Dendreon, Provenge, sipuleucel-T, surveillance, trial | 1 Comment »
